Post-Concussion Syndrome Long-Term Medication: Evidence for Attorneys

James Wong — Founder & Pharmacist, LienScripts | March 26, 2026 | 7 min read

Post-concussion syndrome (PCS) extends medication needs 6 to 18 months beyond the initial injury. The prolonged treatment timeline is objective evidence of ongoing neurological dysfunction that directly supports higher settlement values in personal injury cases.

Post-Concussion Syndrome Long-Term Medication: Evidence for Attorneys

Post-concussion syndrome (PCS) is a clinical condition in which concussion symptoms — headache, dizziness, cognitive difficulty, fatigue, sleep disruption, and mood changes — persist for months or years beyond the expected recovery window. The medication timeline for PCS patients, typically spanning 6 to 18 months and sometimes extending beyond two years, is one of the strongest forms of objective evidence available to personal injury attorneys because it documents ongoing neurological dysfunction through continuous pharmacological treatment.

• PCS affects 15-30% of concussion patients, with symptoms persisting beyond three months after injury (American Academy of Neurology clinical practice guidelines)
• The medication timeline for PCS cases typically spans 6 to 18 months, with some patients requiring treatment for two or more years
• Each month of continued medication fills documents a physician's ongoing clinical judgment that the neurological condition has not resolved
• Medication escalation over time — adding drug classes, increasing doses, switching agents — proves the condition is worsening or refractory to standard treatment
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report that maps the full PCS medication arc from injury through resolution or plateau

Why PCS Duration Matters for Settlement Value

The duration of medical treatment is one of the most powerful factors in personal injury settlement valuation. According to James Wong, PharmD, founder of LienScripts, "A PCS patient with 14 months of continuous pharmacy fills across multiple drug classes presents an objectively different case than a concussion patient who recovered in four weeks. The medication timeline is the evidence that makes that distinction undeniable."

Defense counsel consistently argues that concussions resolve quickly — typically citing the "7-10 day" recovery timeline for sports concussions. PCS cases shatter this narrative, but only when the extended treatment is thoroughly documented.

[!KEY] Each month of continued PCS medication fills represents a documented physician determination that the neurological condition remains active. A 12-month pharmacy lien record with consistent fills across multiple drug classes is evidence that no defense expert can credibly dismiss as symptom exaggeration.

The PCS Medication Timeline: Phases of Treatment

Acute Phase (Weeks 1-4)

The initial medication profile after concussion is typically conservative:

• Acetaminophen for headache (NSAIDs sometimes avoided due to theoretical bleeding concerns in the acute period)
• Ondansetron (Zofran) for nausea and vestibular symptoms
• Short-term rest prescribed alongside medication

At this stage, the medication profile is consistent with a standard concussion expected to resolve. The critical inflection point is what happens next.

Subacute Phase (Months 1-3)

When symptoms persist beyond four weeks, physicians begin prescribing prophylactic and scheduled medications — a clinical decision that reclassifies the condition from acute concussion to emerging PCS:

• Headache prophylaxis initiated: Amitriptyline (10-50 mg nightly), topiramate (25-100 mg daily), or propranolol (40-160 mg daily) started as daily preventive agents
• Vestibular rehabilitation medications: Meclizine continued or replaced with vestibular physical therapy combined with pharmacological support
• Sleep agents prescribed: Trazodone (25-100 mg) or melatonin at prescription doses for sleep-wake cycle disruption
• Cognitive complaints addressed: Referral for neuropsychological testing, sometimes with methylphenidate initiation

[!TIP] The transition from as-needed acute medications to scheduled prophylactic agents is the most important documentation point in PCS cases. This transition — visible in the pharmacy fill record — marks the clinical determination that the concussion has become a chronic condition.

Chronic PCS Phase (Months 3-12)

This phase is characterized by medication optimization — adjustments that document ongoing, active medical management:

• Dose titration: Topiramate increased from 25 mg to 100 mg, amitriptyline increased from 10 mg to 50 mg, indicating the initial dose was insufficient
• Medication switches: Failure of amitriptyline leading to a switch to nortriptyline or venlafaxine documents treatment resistance
• Drug class additions: SSRI added for emerging depression, gabapentin added for persistent headache with neuropathic features, muscle relaxant added for cervicogenic tension contributing to headache
• Specialist prescriptions: Neurology, neuropsychiatry, and pain management providers each adding medications confirms multi-specialty involvement

A 2014 study in the Journal of Head Trauma Rehabilitation found that patients with PCS symptoms at three months post-injury had significantly worse functional outcomes at one year compared to those who recovered within the standard timeframe (PMID: 23640544).

Extended PCS Phase (Months 12-24+)

Some PCS patients require treatment extending well beyond one year. At this stage, the medication record documents:

• Failed taper attempts: Patient tried reducing topiramate but headaches returned, requiring reinstatement — proof the condition is not resolved
• Maintenance therapy: Continued fills of prophylactic agents at stable doses, showing the patient has reached a treatment plateau but still requires medication
• New symptom emergence: Late-developing mood symptoms or cognitive complaints requiring additional medication classes

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "The PCS medication record at month 14 or 16 is often the single most compelling piece of evidence in the demand package. No defense expert can credibly argue that a patient filling five medications 14 months after a concussion is exaggerating symptoms."

[!KEY] Failed medication taper attempts — documented in the pharmacy record as a gap in fills followed by reinstatement — are among the most powerful pieces of evidence in PCS cases. They prove the patient tried to discontinue treatment and could not because the symptoms returned.

Building the PCS Medication Evidence Package

For attorneys building demand packages in PCS cases, the pharmacy lien record should be organized to highlight:

1. Total treatment duration: From first post-injury fill to most recent fill
2. Number of distinct drug classes: Each class represents a separate neurological domain
3. Escalation events: Every dose increase, medication switch, or new drug class addition
4. Failed taper documentation: Gaps followed by refills at the same or higher doses
5. Multi-provider prescribing: Different specialists each contributing to the medication profile

The LienScripts MERIT (Medication Evaluation & Rationale for Injury Treatment) report organizes all of these elements into a pharmacist-signed clinical summary. The MERIT report is specifically designed for inclusion in demand packages and presents the medication timeline in a format that adjusters and defense counsel can follow without medical expertise.

The Pharmacy Lien Removes the Treatment Gap Problem

One of the most damaging patterns in PCS cases is a treatment gap — a period where the patient stopped filling medications because of cost, not because symptoms resolved. Defense counsel will argue that any gap in the medication record proves the patient recovered during that period.

A pharmacy lien through LienScripts eliminates this problem. Every prescription is filled at zero upfront cost, ensuring continuous documentation throughout the PCS recovery arc. There is no gap caused by financial barriers.

Frequently Asked Questions